<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">biob</journal-id><journal-title-group><journal-title xml:lang="ru">Биобезопасность и Биотехнология</journal-title><trans-title-group xml:lang="en"><trans-title>Biosafety and Biotechnology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2707-7241</issn><issn pub-type="epub">2957-5702</issn><publisher><publisher-name>Научно-исследовательский институт проблем биологической безопасности</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.58318/2957-5702-2024-20-29-38</article-id><article-id custom-type="elpub" pub-id-type="custom">biob-145</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>ИЗУЧЕНИЕ БИОЛОГИЧЕСКИХ СВОЙСТВ БАКТЕРИОФАГОВ ПРОТИВ ESKAPE – ПАТОГЕНОВ</article-title><trans-title-group xml:lang="en"><trans-title>STUDYING THE BIOLOGICAL PROPERTIES OF BACTERIOPHAGES AGAINST ESKAPE PATHOGENS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4361-5676</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сырым</surname><given-names>Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Syrym</surname><given-names>N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сырым Назым Cырымқызы</p><p>пгт Гвардейский</p></bio><bio xml:lang="en"><p>Gvardeysky</p></bio><email xlink:type="simple">n.syrym@biosafety.kz</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3312-4045</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Еспембетов</surname><given-names>Б. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Espembetov</surname><given-names>B. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Еспембетов Болат Аманбаевич</p><p>пгт Гвардейский</p></bio><bio xml:lang="en"><p>Gvardeysky</p></bio><email xlink:type="simple">b.yespembetov@biosafety.kz</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3884-4458</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Анарбекова</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Anarbekova</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Анарбекова Актоты Мараткызы</p><p>пгт Гвардейский</p></bio><bio xml:lang="en"><p>Gvardeysky</p></bio><email xlink:type="simple">a.anarbekova@biosafety.kz</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3536-5483</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зинина</surname><given-names>Н. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Zinina</surname><given-names>N. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Зинина Надежда Николаевна</p><p>пгт Гвардейский</p></bio><bio xml:lang="en"><p>Gvardeysky</p></bio><email xlink:type="simple">n.zinina@biosafety.kz</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-9839-6199</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Алпысбаева</surname><given-names>С. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Alpysbaуeva</surname><given-names>S. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Алпысбаева Сабира Егизбаевна</p><p>пгт Гвардейский</p></bio><bio xml:lang="en"><p>Gvardeysky</p></bio><email xlink:type="simple">sabira_31@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0650-7457</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сармыкова</surname><given-names>М. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Sarmykova</surname><given-names>M. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сармыкова Макпал Кенжеевна</p><p>пгт Гвардейский</p></bio><bio xml:lang="en"><p>Gvardeysky</p></bio><email xlink:type="simple">m.sarmykova@biosafety.kz</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9186-0529</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Серикбай</surname><given-names>Е. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Serikbay</surname><given-names>E. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Серикбай Елдос</p><p>пгт Гвардейский</p></bio><bio xml:lang="en"><p>Gvardeysky</p></bio><email xlink:type="simple">y.serikbay@biosafety.kz</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4585-7476</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Абдимухтар</surname><given-names>А. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Abdimukhtar</surname><given-names>A. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Абдимухтар Азамат Рустемулы</p><p>пгт Гвардейский</p></bio><bio xml:lang="en"><p>Gvardeysky</p></bio><email xlink:type="simple">a.abdimukhtar@biosafety.kz</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-1906-746X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Толеухан</surname><given-names>А. Т.</given-names></name><name name-style="western" xml:lang="en"><surname>Toleukhan</surname><given-names>A. T.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Толеухан Алинур Тулегенулы</p><p>пгт Гвардейский</p></bio><bio xml:lang="en"><p>Gvardeysky</p></bio><email xlink:type="simple">a.toleukhan@biosafety.kz</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0001-3948-7966</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мауленбаева</surname><given-names>М.</given-names></name><name name-style="western" xml:lang="en"><surname>Maulenbaeva</surname><given-names>M. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мауленбаева Меруерт</p><p>пгт Гвардейский</p></bio><bio xml:lang="en"><p>Gvardeysky</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4585-7476</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ержігіт</surname><given-names>Б. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Erzhigit</surname><given-names>B. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ержігіт Бекзат Бауыржанұлы</p><p>пгт Гвардейский</p></bio><bio xml:lang="en"><p>Gvardeysky</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1998-8798</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Абдықалық</surname><given-names>А. Ә.</given-names></name><name name-style="western" xml:lang="en"><surname>Abdykalyk</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Абдықалық Ақбөпе Әбдіғалымқызы</p><p>пгт Гвардейский</p></bio><bio xml:lang="en"><p>Gvardeysky</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мауленбай</surname><given-names>А. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Maulenbay</surname><given-names>A. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мауленбай Акерке Даулеткызы</p><p>пгт Гвардейский</p></bio><bio xml:lang="en"><p>Gvardeysky</p></bio><email xlink:type="simple">maulenbay.id@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ТОО «Научно-исследовательский институт проблем биологической безопасности»<country>Казахстан</country></aff><aff xml:lang="en">«Research Institute for Biological Safety Problems» LLP<country>Kazakhstan</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>16</day><month>09</month><year>2024</year></pub-date><volume>0</volume><issue>20</issue><fpage>29</fpage><lpage>38</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Сырым Н., Еспембетов Б.А., Анарбекова А.М., Зинина Н.Н., Алпысбаева С.Е., Сармыкова М.К., Серикбай Е.Б., Абдимухтар А.Р., Толеухан А.Т., Мауленбаева М.M., Ержігіт Б.Б., Абдықалық А.Ә., Мауленбай А.Д., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Сырым Н., Еспембетов Б.А., Анарбекова А.М., Зинина Н.Н., Алпысбаева С.Е., Сармыкова М.К., Серикбай Е.Б., Абдимухтар А.Р., Толеухан А.Т., Мауленбаева М., Ержігіт Б.Б., Абдықалық А.Ә., Мауленбай А.Д.</copyright-holder><copyright-holder xml:lang="en">Syrym N., Espembetov B.A., Anarbekova A.M., Zinina N.N., Alpysbaуeva S.E., Sarmykova M.K., Serikbay E.B., Abdimukhtar A.R., Toleukhan A.T., Maulenbaeva M.M., Erzhigit B.B., Abdykalyk A.A., Maulenbay A.D.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.biosafety.kz/jour/article/view/145">https://journal.biosafety.kz/jour/article/view/145</self-uri><abstract><p>Бактериальные инфекции, вызываемые МЛУ-штаммами, входят в список самых опасных угроз для мирового общественного здравоохранения. Наибольшее количество случаев устойчивости детектируют среди так называемых ESKAPE патогенов (от начальных букв Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa и Enterobacter cloacae). Бактерии этой группы вызывают угрожающие жизни внутрибольничные инфекции, особенно у людей с ослабленным иммунитетом и хроническими заболеваниями. В статье рассмотрены обоснования фаговой терапии, клинические проблемы и предложена фаготерапия как эффективное средство против ESKAPE патогенов, охарактеризованы их некоторые биологические свойства(действие высокой температуры, устойчивость к воздействию хлороформа и изучение влияния изменений значений рН на активность бактериофагов). В качестве физического фактора изучали действие высокой температуры на бактериофаги, а в качестве химического - действие хлороформа. В результате исследований температурной устойчивости нами было установлено, что прогревание фагов в течение 30 мин при 60 °С не оказывало влияния на их активность, бактериофаги сохраняют активность при значении рН в пределах от 7.0 до 8.0, устойчивы к воздействию хлороформом в течение 45 мин. При этом следует отметить, что щелочная среда буферного раствора незначительно влияла на снижение активности изучаемого бактериофагов. При этом нахождение бактериофага в кислой среде в большей степени отражалось на снижении его инфекционной способности.</p></abstract><trans-abstract xml:lang="en"><p>Bacterial infections caused by multidrug-resistant (MDR) strains are among the most dangerous threats to global public health. The highest number of resistance cases is detected among the so-called ESKAPE pathogens (from the initials of Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.). These bacteria cause life-threatening nosocomial infections, especially in individuals with weakened immune systems and chronic diseases. The article discusses the rationale for phage therapy, clinical problems, and proposes phage therapy as an effective means against ESKAPE pathogens. It characterizes some of their biological properties (effect of high temperature, resistance to chloroform exposure, and the impact of pH changes on bacteriophage activity). High temperature was studied as a physical factor, and chloroform exposure as a chemical factor affecting bacteriophages. The study found that heating phages for 30 minutes at 60°C did not affect their activity. They maintained activity within a pH range of 7.0 to 7.5 and were resistant to chloroform exposure for 40 minutes. It should be noted that the alkaline environment of the buffer solution slightly affected the activity of the studied bacteriophages, while the acidic environment had a more significant impact on reducing their infectivity.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>микробиология</kwd><kwd>бактерий</kwd><kwd>бактериофаги</kwd><kwd>ESKAPE-патогены</kwd></kwd-group><kwd-group xml:lang="en"><kwd>microbiology</kwd><kwd>bacteria</kwd><kwd>bacteriophages</kwd><kwd>ESKAPE pathogens</kwd></kwd-group><funding-group xml:lang="ru"><funding-statement>Исследование выполнено при финансовой поддержке Комитета науки Министерства науки и высшего образования Республики Казахстан (грант № BR218004/0223).</funding-statement></funding-group><funding-group xml:lang="en"><funding-statement>LLP RIBSP</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Laxminarayan R. Antibiotic resistance – the need for global solutionsv [Tekst] / R. Laxminarayan A. Duse, C. Wattal, A.K. Zaidi, H.F Wertheim, N. Sumpradit [et al.] // The Lancet Infectious Diseases. - 2013.-V. 13(12). - P. 1057–1098. [URL: https://doi.org/10.1016/S1473-3099(13)70318-9].</mixed-citation><mixed-citation xml:lang="en">Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K., Wertheim, H. F., Sumpradit, N., ... &amp; others. (2013). Antibiotic resistance – the need for global solutions. The Lancet Infectious Diseases, 13(12), 1057–1098. https://doi.org/10.1016/S1473-3099(13)70318-9.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ayukekbong J A. The threat of antimicrobial resistance in developing countries: causes and control strategies [Tekst] / J.A Ayukekbong, M. Ntemgwa, A.N. Atabe // Antimicrob Resist Infection Control. – 2017. V.15(6):47. [URL: https://doi.org/10.1186/s13756-017-0208-x].</mixed-citation><mixed-citation xml:lang="en">Ayukekbong, J. A., Ntemgwa, M., &amp; Atabe, A. N. (2017). The threat of antimicrobial resistance in developing countries: Causes and control strategies. Antimicrob Resist Infection Control, 15(6), 47. https://doi.org/10.1186/s13756-017-0208-x.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bloom DE, Cadarette D. Infectious Disease Threats in the Twenty-First Century: Strengtheningthe Global Response [Tekst] / D.E Bloom, D. Cadarette // Frontiers in Immunology. – 2019. - V. 10:549. [https://doi.org/10.3389/fimmu.2019.00549].</mixed-citation><mixed-citation xml:lang="en">Bloom, D. E., &amp; Cadarette, D. (2019). Infectious disease threats in the twenty-first century: Strengthening the global response. Frontiers in Immunology, 10, 549. https://doi.org/10.3389/fimmu.2019.00549.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Collignon PJ. World Health Organization Ranking of Antimicrobials According to Their Importance in Human Medicine: A Critical Step for Developing Risk Management Strategies to Control Antimicrobial Resistance from Food Animal Production [Tekst] / P. J, Collignon, J.M., Conly, A Andremont, S.A. McEwen, A. Aidara-Kane [et al.] // Clinical Infection Diseases. – 2016. - V. 63(8): - P.1087–1093. [URL: https://doi.org/10.1093/cid/ciw475].</mixed-citation><mixed-citation xml:lang="en">Collignon, P. J., Conly, J. M., Andremont, A., McEwen, S. A., Aidara-Kane, A., ... &amp; others. (2016). World Health Organization ranking of antimicrobials according to their importance in human medicine: A critical step for developing risk management strategies to control antimicrobial resistance from food animal production. Clinical Infectious Diseases, 63(8), 1087–1093. https://doi.org/10.1093/cid/ciw475.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Adeniji F. Global analysis of strategies to tackle antimicrobial resistance [Tekst] / F. Adeniji International Journal Pharmacy Practice. – 2018. - V. 26(1). - P.85–89. [URL: https://doi.org/10.1111/ijpp.12365].</mixed-citation><mixed-citation xml:lang="en">Adeniji, F. (2018). Global analysis of strategies to tackle antimicrobial resistance. International Journal of Pharmacy Practice, 26(1), 85–89. https://doi.org/10.1111/ijpp.12365.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Veeraraghavan B. Antimicrobial susceptibility profile &amp; resistance mechanisms of Global Antimicrobial Resistance Surveillance System (GLASS) priority pathogens from India [Tekst] / B. Veeraraghavan, K. Walia // Indian Journal of Medical Research. – 2019. - V. 149(2). - Р.87–96. [URL: https://doi.org/10.4103/ijmr.IJMR_214_18].</mixed-citation><mixed-citation xml:lang="en">Veeraraghavan, B., &amp; Walia, K. (2019). Antimicrobial susceptibility profile &amp; resistance mechanisms of Global Antimicrobial Resistance Surveillance System (GLASS) priority pathogens from India. Indian Journal of Medical Research, 149(2), 87–96. https://doi.org/10.4103/ijmr.IJMR_214_18.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Arepyeva MA. A mathematical model for predicting the development of bacterial resistance based on the relationship between the level of antimicrobial resistance and the volume of antibiotic consumption [Tekst] / M. A. Arepyeva, A. S Kolbin, S. V. Sidorenko, R. Lawson, AA. Kurylev, Y. E. Balykina [et al.] // Journal of Global Antimicrobial Resistance. – 2017. - V. 8. - Р.148–156. [URL: https://doi.org/10.1016/j.jgar.2016.11.010]</mixed-citation><mixed-citation xml:lang="en">Arepyeva, M. A., Kolbin, A. S., Sidorenko, S. V., Lawson, R., Kurylev, A. A., Balykina, Y. E., ... &amp; others. (2017). A mathematical model for predicting the development of bacterial resistance based on the relationship between the level of antimicrobial resistance and the volume of antibiotic consumption. Journal of Global Antimicrobial Resistance, 8, 148–156. https://doi.org/10.1016/j.jgar.2016.11.010.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Mulani MS. Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review [Tekst] / M.S. Mulani, E.E Kamble, S.N Kumkar, M.S Tawre, K.R Pardesi // Frontiers in Microbiology. – 2019. - V. 10:539. [URL: https://doi.org/10.3389/fmicb.2019.00539]</mixed-citation><mixed-citation xml:lang="en">Mulani, M. S., Kamble, E. E., Kumkar, S. N., Tawre, M. S., &amp; Pardesi, K. R. (2019). Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: A review. Frontiers in Microbiology, 10, 539. https://doi.org/10.3389/fmicb.2019.00539.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Santajit S. Mechanisms of antimicrobial resistance in ESKAPE pathogens [Tekst] / S. Santajit, N. Indrawattana // BioMed Research International. – 2016. - V. (2). - Р. 1–8. [URL: https://doi.org/10.1155/2016/2475067]</mixed-citation><mixed-citation xml:lang="en">Santajit, S., &amp; Indrawattana, N. (2016). Mechanisms of antimicrobial resistance in ESKAPE pathogens. BioMed Research International, (2), 1–8. https://doi.org/10.1155/2016/2475067.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">M100 Performance Standards for Antimicrobial Susceptibility Testing An informational supplement for global application developed through the Clinical and Laboratory Standards Institute consensus process // 29 th Edition. - 2019.</mixed-citation><mixed-citation xml:lang="en">M100 Performance Standards for Antimicrobial Susceptibility Testing. (2019). An informational supplement for global application developed through the Clinical and Laboratory Standards Institute consensus process (29th ed.).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Джиоев, Ю.П. Анализ проблемы «супербактерий» и современные подходы к ее решению [Tekst] / Ю.П. Джиоев, В.И. Злобин, В.П. Саловарова, Л.А. Степаненко, О.Н. Рева, А.Ю. Борисенко, Н.П. Перетолчина, Ю.С. Букин // Известия Вузов. Прикладная химия и биотехнология. - 2019. - Том 9. - N 4.</mixed-citation><mixed-citation xml:lang="en">Djioev, Y. P., Zlobin, V. I., Salovarova, V. P., Stepanenko, L. A., Reva, O. N., Borisенко, A. Y., Peretolchina, N. P., &amp; Bukin, Y. S. (2019). Analysis of the problem of "superbugs" and modern approaches to solving it. Izvestiya Vuzov. Applied Chemistry and Biotechnology, 9(4).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Adeniji F. Global analysis of strategies to tackle antimicrobial resistance [Tekst] / F. Adeniji // International Journal Pharmacy Practice. – 2018. - V. 26 (1). - Р. 85–89. [URL: https://doi.org/10.1111/ijpp.12365].</mixed-citation><mixed-citation xml:lang="en">Adeniji, F. (2018). Global analysis of strategies to tackle antimicrobial resistance. International Journal of Pharmacy Practice, 26(1), 85–89. https://doi.org/10.1111/ijpp.12365.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Mulani MS. Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review [Tekst] / MS. Mulani, EE. Kamble, SN. Kumkar, MS. Tawre, KR. Pardesi // Frontiers in Microbiology. – 2019. - V. 10:539. [https://doi.org/10.3389/fmicb.2019.00539].</mixed-citation><mixed-citation xml:lang="en">Mulani, M. S., Kamble, E. E., Kumkar, S. N., Tawre, M. S., &amp; Pardesi, K. R. (2019). Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: A review. Frontiers in Microbiology, 10, 539. https://doi.org/10.3389/fmicb.2019.00539.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Aslam, S. Lessons learned from the first 10 consecutive cases of intravenous bacteriophage therapy to treat multidrug-resistant bacterial infections at a single center in the United States [Tekst] / S. Aslam, E. Lampley, D. Wooten, M. Karris, C. Benson, S. Strathdee [et al.] // Open Forum Infect. Dis. - 2020. V. 7: ofaa 389. [URL: doi: 10.1093/ofid/ofaa389]</mixed-citation><mixed-citation xml:lang="en">Aslam, S., Lampley, E., Wooten, D., Karris, M., Benson, C., Strathdee, S., ... &amp; others. (2020). Lessons learned from the first 10 consecutive cases of intravenous bacteriophage therapy to treat multidrug-resistant bacterial infections at a single center in the United States. Open Forum Infectious Diseases, 7, ofaa 389. https://doi.org/10.1093/ofid/ofaa389.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
